<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02853682</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0027</org_study_id>
    <nct_id>NCT02853682</nct_id>
  </id_info>
  <brief_title>Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery</brief_title>
  <acronym>GLYNO</acronym>
  <official_title>Characterization of Endothelial Dysfunction as a Function of Hyperaemia of the Brachial Artery During Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The glycocalyx is a layer of proteins and complex sugars covering the endothelium of vessels.
      Its role as capillary filtration control is important. In case of alteration of the
      glycocalyx, experimental models and some clinical studies show an increased capillary leak
      responsible for interstitial edema. The analysis of glycocalyx in routine care is important
      to guide volume expansion. Indeed, the literature provides evidence about the poor prognosis
      of excess water and its impact on organ. This analysis challenge is to justify filling
      solution of choice according to the characteristic of this capillary leakage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extra corporeal circulation and aortic clamp induce ischemia-reperfusion damages.

      Vascular damages are represented by first glycocalyx, a layer of endovascular vessel
      proteoglycans, responsible for fluid permeability and secondly by nitro oxygen liberation
      responsible for vascular tonus.

      The investigators suppose that both functions are impaired after cardiac surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>glycocalyx proteins 1</measure>
    <time_frame>48 hours</time_frame>
    <description>proteoglycan in patient plasma is assayed.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Capillary Leak Syndrome</condition>
  <arm_group>
    <arm_group_label>presence of a vascular dysfunction</arm_group_label>
    <description>plasma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>absence of vascular dysfunction</arm_group_label>
    <description>plasma</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>plasma</intervention_name>
    <description>assesment of glycocalyx protein</description>
    <arm_group_label>presence of a vascular dysfunction</arm_group_label>
    <arm_group_label>absence of vascular dysfunction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients going for cardiac surgery enrolled for 48 hours after surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cardiac surgery

        Exclusion Criteria:

          -  auricular fibrillation

          -  endocarditis

          -  aortic dissection

          -  end stage chronic renal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osama ABOU ARAB, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanuel LORNE, MD-PhD</last_name>
    <role>Study Director</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre-Gregoire GUINOT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Osama ABOU ARAB, MD</last_name>
    <phone>322087836</phone>
    <phone_ext>+33</phone_ext>
    <email>abouarab.osama@chu-amiens.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Osama ABOU ARAB, MD</last_name>
    <email>abouarab.osama@chu-amiens.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osama ABOU ARAB, MD</last_name>
      <phone>+33322087836</phone>
      <email>abouarab.osama@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002 Jan 16;39(2):257-65. Erratum in: J Am Coll Cardiol 2002 Mar 20;39(6):1082.</citation>
    <PMID>11788217</PMID>
  </reference>
  <reference>
    <citation>Becker BF, Jacob M, Leipert S, Salmon AH, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015 Sep;80(3):389-402. doi: 10.1111/bcp.12629. Epub 2015 May 22. Review.</citation>
    <PMID>25778676</PMID>
  </reference>
  <reference>
    <citation>Chawla LS, Ince C, Chappell D, Gan TJ, Kellum JA, Mythen M, Shaw AD; ADQI XII Fluids Workgroup. Vascular content, tone, integrity, and haemodynamics for guiding fluid therapy: a conceptual approach. Br J Anaesth. 2014 Nov;113(5):748-55. doi: 10.1093/bja/aeu298. Epub 2014 Sep 17.</citation>
    <PMID>25231767</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2016</study_first_submitted>
  <study_first_submitted_qc>July 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2016</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>glycocalyx</keyword>
  <keyword>capillary leak syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperemia</mesh_term>
    <mesh_term>Capillary Leak Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

